Lupus eritematoso asociado a eritema multiforme: Síndrome de Rowell. Reporte del primer caso en Chile
Artículo

Open/ Download
Access note
Acceso Abierto
Publication date
2020Metadata
Show full item record
Cómo citar
Heredia, Loreto
Cómo citar
Lupus eritematoso asociado a eritema multiforme: Síndrome de Rowell. Reporte del primer caso en Chile
Abstract
Rowell's syndrome is characterized by an association of lupus erythematosus and erythema multiforme, with distinctive laboratory findings. Its treatment is similar to lupus. We report a 16-year-old female presenting with skin lesions, laboratory and histology consistent with this entity. Because of the spread of cutaneous involvement and development of epidermal detachment, she required therapy with intravenous corticosteroids and gamma globulin. El síndrome de Rowell se caracteriza por una asociación de lupus eritematoso
y eritema multiforme, con hallazgos de laboratorio distintivos. Su tratamiento es
similar al lupus. Presentamos una mujer de 16 años que presenta lesiones cutáneas,
laboratorio e histología compatibles con esta entidad. Debido a la propagación de
afectación cutánea y desarrollo de desprendimiento epidérmico, requirió
terapia con corticosteroides intravenosos y gammaglobulina
Indexation
Artículo de publicación ISI Artículo de publicación SCIELO
Quote Item
Rev. Med. Chile 2020; 148: 1690-1693
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Pons-Estel, Bernardo A.; Bonfa, Eloisa; Soriano, Enrique R.; Cardiel, Mario H.; Izcovich, Ariel; Popoff, Federico; Criniti, Juan M.; Vásquez, Gloria; Massardo, Loreto; Duarte, Margarita; Barile-Fabris, Leonor A.; García, Mercedes A.; Amigo, Mary Carmen; Espada, Gracie (BMJ Publishing Group, 2018)© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune ...
-
Abumohor,; Cerda,; Neira,; Palma,; Alvarado Alvarado, José Luis; Basualdo,; Bravo, Roberto; Guzmán Guzmán, Iris P (1991)Anti-cardiolipin antibodies have been recently described in patients with systemic lupus erythematosus and other autoimmune disorders. Venous and arterial thrombosis, thrombocytopenia and recurrent abortion have been ...
-
Reátegui-Sokolova, Cristina; Ugarte Gil, Manuel; Harvey, Guillermina B.; Wojdyla, Daniel; Pons Estel, Guillermo J.; Quintana, Rosana; Serrano Morales, Rosa M.; Sacnun, Mónica P.; Catoggio, Luis J.; Soriano, Enrique R.; García, Mercedes A.; Saurit, Verónica; Alvarellos, Alejandro; Caeiro, Francisco; Berbotto, Guillermo A.; Sato, Emilia I.; Borba Neto, Eduardo Ferreira; Bonfa, Eloisa; de Oliveira e Silva Montandon, Ana Carolina; Da Silva, Nilzio A; Cavalcanti, Fernando; Chacón Vásquez, Gloria; Guibert Toledano, Marlene; Reyes Llerena, Gil A.; Massardo, Loreto; Neira Quiroga, Óscar; Cardiel, Mario H.; Barile Fabris, Leonor A.; Amigo, Mary Carmen; Silveira, Luis H.; Portela-Hernández, Margarita; García de la Torre, Ignacio; Segami, María Inés; Chacón-Diaz, Rosa; Esteva Spinetti, María H.; Alarcón, Graciela S.; Pons-Estel, Bernardo A. (BMJ, 2020)Aim A decrease in proteinuria has been considered protective from renal damage in lupus nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to identify the predictors of renal damage ...